Bremer, B. Et Al. 2020. Residual low HDV viremia is associated with HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis D (delta): results from the HIDIT-II study. JOURNAL OF HEPATOLOGY , vol.73 .

Bremer, B., Anastasiou, O., Hardtke, S., Caruntu, F. A., Curescu, M. G., Yalcin, K., ... Akarca, U. S.(2020). Residual low HDV viremia is associated with HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis D (delta): results from the HIDIT-II study. JOURNAL OF HEPATOLOGY , vol.73.

Bremer, Birgit Et Al. "Residual low HDV viremia is associated with HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis D (delta): results from the HIDIT-II study," JOURNAL OF HEPATOLOGY , vol.73, 2020

Bremer, Birgit Et Al. "Residual low HDV viremia is associated with HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis D (delta): results from the HIDIT-II study." JOURNAL OF HEPATOLOGY , vol.73, 2020

Bremer, B. Et Al. (2020) . "Residual low HDV viremia is associated with HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis D (delta): results from the HIDIT-II study." JOURNAL OF HEPATOLOGY , vol.73.

@article{article, author={Birgit Bremer Et Al. }, title={Residual low HDV viremia is associated with HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis D (delta): results from the HIDIT-II study}, journal={JOURNAL OF HEPATOLOGY}, year=2020}